[CIS PIDD] [cis-pidd] XLA+UC

[Mel.Berger at cslbehring.com]

Talk to Scott Snapper at Boston Children'/Harvard. He is studying early-onset bowel disease in patientsa with PID.:



scott.snapper at childrens.harvard.edu<mailto:scott.snapper at childrens.harvard.edu>



Mel

________________________________
From: Church, Joseph [JChurch at chla.usc.edu]
Sent: Thursday, January 31, 2013 10:32 PM
To: CIS-PIDD
Subject: [cis-pidd] XLA+UC

Colleagues:

An 8yo boy with XLA was just diagnosed as having "ulcerative colitis."

I could find no reference to this specific association.

Has anyone seen this combination?

Should I recommend a second Pathology opinion?

Joe Church
Children's Hospital Los Angeles

---------------------------------------------------------------------
CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain confidential
or legally privileged information. Any unauthorized review, use, disclosure
or distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of this original message.

---------------------------------------------------------------------

---

The CIS-PIDD listserv is supported by:

[http://www.clinimmsoc.org/UserFiles/image/cis-pidd-list-logo_v1.jpg]
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org<https://cis.execinc.com/edibo/Signup> to join!

You are currently subscribed to cis-pidd as: mel.berger at cslbehring.com<mailto:mel.berger at cslbehring.com>.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824392.4a5e4b979d2e59f93eea8a6e1962edf8&n=T&l=cis-pidd&o=42655296

This email, including any attachments, is confidential and contains proprietary content and may be legally privileged. This transmission is intended only for the designated recipient(s), and any duplication or distribution, in any form or part, without the written consent of the sender is strictly prohibited. These confidentiality protections apply even if you received this transmission in error, in which case you should delete the message, disregard its contents and notify the sender of the mistake. CSL Behring

---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org to join!

You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=42655324
or send a blank email to leave-42655324-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org